Tech Company Financing Transactions

UNITY Biotechnology Funding Round

UNITY Biotechnology secured a $55 million Series C funding round on 3/20/2018. Investors included 6 Dimensions Capital, Altitude Life Science Ventures and Arch Venture Partners.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series C
Proceeds Purpose
Proceeds from this financing will be used to advance the company's lead senolytic drug candidates into human clinical trials.

Company Information

Company Status
Mailing Address
3280 Bayshore Blvd. 100
Brisbane, CA 94005
Email Address
Unity Biotechnology (Nasdaq: UBX) Imagine a future in which you age, but without the diseases your parents got. A future in which it doesn't hurt to grow old. At UNITY, we design therapeutics that prevent, halt, or reverse diseases of aging. Our medicines are designed to lengthen healthspan, the amount of time you live in good health.
UNITY Biotechnology LinkedIn Company Profile
Social Media
UNITY Biotechnology Company Twitter Account
Company News
UNITY Biotechnology News
UNITY Biotechnology on Facebook
UNITY Biotechnology on YouTube

Management Team

Email & Social
Chief Executive Officer
Keith Leonard
  Keith Leonard LinkedIn Profile  Keith Leonard Twitter Account  Keith Leonard News  Keith Leonard on Facebook
Chief Financial Officer
Robert Goeltz
  Robert Goeltz LinkedIn Profile  Robert Goeltz Twitter Account  Robert Goeltz News  Robert Goeltz on Facebook
Chief Medical Officer
Jamie Dananberg
  Jamie Dananberg LinkedIn Profile  Jamie Dananberg Twitter Account  Jamie Dananberg News  Jamie Dananberg on Facebook
Chief Scientific Officer
Dan Marquess
  Dan Marquess LinkedIn Profile  Dan Marquess Twitter Account  Dan Marquess News  Dan Marquess on Facebook
Nathaniel David
  Nathaniel David LinkedIn Profile  Nathaniel David Twitter Account  Nathaniel David News  Nathaniel David on Facebook
VP - General Counsel
Tamara Tompkins
  Tamara Tompkins LinkedIn Profile  Tamara Tompkins Twitter Account  Tamara Tompkins News  Tamara Tompkins on Facebook



Browse more venture capital transactions:

Prev: 3/20/2018: PHLUR venture capital transaction
Next: 3/20/2018: SkyCision venture capital transaction


Share this article


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary